05 October 2021>: Original Paper
Wilson Disease in Children; Chelation Therapy or Liver Transplantation? A 10-Year Experience from Pakistan
Sahira Aaraj 1CDE* , Sabeen Abid Khan 1DF , Naurin Ali 1BF , Munir I. Iqbal Malik 2ADF , Faisal Saud Dar 3AFDOI: 10.12659/AOT.932606
Ann Transplant 2021; 26:e932606
Table 4 King’s Wilson indices of individual patients with Wilson disease.
Group 1Oral chelationn=34 | Group 2Liver transplantn=11 | Group 3Asymptomaticn=3 | |
---|---|---|---|
Bilirubin (μmol/L) | 5.30 (0.20–51.13) | 11.8 (1.1–30.9) | 0.473 (0.36–0.58) |
INR | 1.58 (1–4.8) | 3.5 (1.1–8.02) | 1.33 (1.05–1.09) |
Albumin (g/L) | 3.1 (1.5–4.8) | 2.62 (1.6–3.7) | 2.8 (2.2–3.2) |
ALT (IU/L) | 101.6 (10–674) | 121.36 (47–327) | 31 (27–34) |
AST (IU/L) | 103.80 (18–434) | 134.45 (38–280) | 39.3 (30.9–46) |
ALP (IU/L) | 328.46 (13–1198) | 233.3 (92–849) | 616 (194–1451) |
Hb (g/L) | 11.4 (6–14.6) | 11.04 (8.30–13.9) | 11.2 (10.4–12.4) |
Leucocyte count (10/L) | 7215.75 (1750–20700) | 8624.54 (1200–15600) | 7400 (6200–9000) |
Kings Wilsons Index | 5.34 (1–14) | 11 (6–14) | 4 (2–6) |